List of SBIR/STTR awards granted to Arisan Therapeutics
Arisan TherapeuticsName | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Arisan Therapeutics in May, 2019 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AI127055-02A1 | Phase II | 1,000,000 | May 1, 2019 | |||||||
A SBIR Phase II contract was awarded to Arisan Therapeutics in September, 2021 for $269,361.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911SR21-C-5001 | Phase II | 269,361 | September 25, 2021 | |||||||
A SBIR Phase II contract was awarded to Arisan Therapeutics in March, 2020 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AI112097-05 | Phase II | 1,000,000 | March 2, 2020 | |||||||
A SBIR Phase I contract was awarded to Arisan Therapeutics in February, 2020 for $96,111.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911QY-20-P-0080 | Phase I | 96,111 | February 6, 2020 | |||||||
A SBIR Phase I contract was awarded to Arisan Therapeutics in March, 2018 for $650,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI138878-01 | Phase I | 650,000 | March 1, 2018 | |||||||
A SBIR Phase I contract was awarded to Arisan Therapeutics in February, 2020 for $167,442.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911QY-20-P-0069 | Phase I | 167,442 | February 3, 2020 | |||||||
A SBIR Phase II contract was awarded to Arisan Therapeutics in September, 2021 for $587,720.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911SR-21-C-5049 | Phase II | 587,720 | September 30, 2021 | |||||||
A SBIR Phase I contract was awarded to Arisan Therapeutics in April, 2016 for $1,800,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI112097-01 | Phase I | 1,800,000 | April 1, 2016 | |||||||
A SBIR Phase II contract was awarded to Arisan Therapeutics in April, 2016 for $3,000,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI112097-03 | Phase II | 3,000,000 | April 1, 2016 | |||||||
A STTR Phase I contract was awarded to Arisan Therapeutics in August, 2016 for $300,000.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI127055-01 | Phase I | 300,000 | August 1, 2016 | |||||||
A SBIR Phase I contract was awarded to Arisan Therapeutics in February, 2015 for $300,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI118207-01 | Phase I | 300,000 | February 1, 2015 | |||||||
A SBIR Phase I contract was awarded to Arisan Therapeutics for $300,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI106266-01A1 | Phase I | 300,000 | ||||||||
A SBIR Phase I contract was awarded to Arisan Therapeutics for $449,400.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI104106-01 | Phase I | 449,400 | ||||||||
A SBIR Phase I contract was awarded to Arisan Therapeutics for $473,362.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI096830-01 | Phase I | 473,362 | ||||||||
A SBIR Phase I contract was awarded to Arisan Therapeutics for $445,261.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI093035-01A1 | Phase I | 445,261 |
